30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Marc Tessier-Lavigne

Track

Insider profile

Currently holds positions in Genentech Inc and Regeneron Pharmaceuticals Inc

Performance

Overall performance
2.0
Performance over holding periods
2.0
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 45% 68% 82%
Transactions
14 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Vice President - Research Drug Discovery Genentech Inc June 4, 2008 -
Independent Director Regeneron Pharmaceuticals Inc Nov. 21, 2011 -
Chairman of the Board Agios Pharmaceuticals Inc Jan. 1, 2015 - Aug. 26, 2016
Independent Director Juno Therapeutics Inc Jan. 1, 2014 - Aug. 26, 2016
Independent Director Pfizer Inc Dec. 12, 2011 - May 14, 2015
Independent Director Agios Pharmaceuticals Inc Sept. 1, 2011 - Jan. 1, 2015
Marc Tessier-Lavigne's trades of Regeneron Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-10-03 2023-10-03
PrS Proposed sale
76,253
12.96
US$1,715,446 		76,253 12.96 US$1,715,446
2022-11-28 2022-11-23
PlS Planned sale
14,267 +16.5%
203.98
US$50,980 		14,267 +16.5% 203.98 US$50,980
2022-11-03 2022-11-02
PlS Planned sale
18,567 +28.4%
323.57
US$4,746,537 		18,567 +28.4% 323.57 US$4,746,537
2022-11-03 2022-11-01
PlS Planned sale
8,748 -0.5%
30.20
US$264,190 		8,748 -0.5% 30.20 US$264,190
2022-10-03 2022-10-03
PlS Planned sale
3,612 -61.4%
718.00
US$2,593,416 		3,612 -61.4% 718.00 US$2,593,416
2022-10-03 2022-09-30
PlS Planned sale
3,428 -60.2%
698.00
US$2,392,744 		3,428 -60.2% 698.00 US$2,392,744
2022-10-03 2022-09-29
PlS Planned sale
20 -0.9%
704.83
US$14,097 		20 -0.9% 704.83 US$14,097
2022-10-03 2022-09-29
PlS Planned sale
16 -0.7%
702.36
US$11,238 		16 -0.7% 702.36 US$11,238
2022-10-03 2022-09-29
PlS Planned sale
80 -3.4%
699.82
US$55,986 		80 -3.4% 699.82 US$55,986
2022-10-03 2022-09-29
PlS Planned sale
208 -8.0%
698.44
US$145,276 		208 -8.0% 698.44 US$145,276
2022-10-03 2022-09-29
PlS Planned sale
160 -5.8%
697.29
US$111,566 		160 -5.8% 697.29 US$111,566
2022-10-03 2022-09-29
PlS Planned sale
85 -3.0%
696.13
US$59,171 		85 -3.0% 696.13 US$59,171
2022-10-03 2022-09-29
PlS Planned sale
554 -16.3%
691.59
US$383,141 		554 -16.3% 691.59 US$383,141
2022-10-03 2022-09-29
PlS Planned sale
692 -16.9%
690.65
US$477,930 		692 -16.9% 690.65 US$477,930
2022-10-03 2022-09-29
PlS Planned sale
1,009 -19.8%
689.56
US$695,766 		1,009 -19.8% 689.56 US$695,766
2022-10-03 2022-09-29
PlS Planned sale
637 -11.1%
688.71
US$438,708 		637 -11.1% 688.71 US$438,708
2022-10-03 2022-09-29
PlS Planned sale
321 -5.3%
687.90
US$220,816 		321 -5.3% 687.90 US$220,816
2022-10-03 2022-09-29
PlS Planned sale
16 -0.3%
686.89
US$10,990 		16 -0.3% 686.89 US$10,990
2022-08-25 2022-08-23
PlS Planned sale
100 -0.0%
32.43
US$3,243 		100 -0.0% 32.43 US$3,243
2022-08-25 2022-08-23
PlS Planned sale
19,900 -1.0%
31.61
US$629,039 		19,900 -1.0% 31.61 US$629,039
2022-07-27 2022-07-25
S Sale
200 -0.0%
36.15
US$7,230 		200 -0.0% 36.15 US$7,230
2022-07-27 2022-07-25
S Sale
19,800 -1.0%
35.60
US$704,880 		19,800 -1.0% 35.60 US$704,880
2022-03-25 2022-03-23
S Sale
11,598 -0.6%
34.14
US$395,956 		11,598 -0.6% 34.14 US$395,956
2022-03-25 2022-03-23
S Sale
8,402 -0.4%
33.40
US$280,627 		8,402 -0.4% 33.40 US$280,627
2022-03-23 2022-03-21
PlS Planned sale
7,439 -76.6%
690.00
US$5,132,910 		7,439 -76.6% 690.00 US$5,132,910
2022-03-18 2022-03-17
PlS Planned sale
7,830 -77.5%
680.00
US$5,324,400 		7,830 -77.5% 680.00 US$5,324,400
2022-03-18 2022-03-16
PlS Planned sale
4,361 -65.8%
675.00
US$2,943,675 		4,361 -65.8% 675.00 US$2,943,675
2021-12-10 2021-12-09
PlS Planned sale
3,784 -64.6%
665.00
US$2,516,360 		3,784 -64.6% 665.00 US$2,516,360
2021-06-08 2021-06-07
PlS Planned sale
700 -0.0%
71.06
US$49,744 		700 -0.0% 71.06 US$49,744
2021-06-08 2021-06-07
PlS Planned sale
93,678 -3.6%
70.35
US$6,589,779 		93,678 -3.6% 70.35 US$6,589,779
2021-05-24 2021-05-24
PlS Planned sale
8,806 -0.3%
60.03
US$528,580 		8,806 -0.3% 60.03 US$528,580
2021-05-24 2021-05-21
PlS Planned sale
37,957 -1.5%
60.13
US$2,282,468 		37,957 -1.5% 60.13 US$2,282,468
2021-05-05 2021-05-03
PlS Planned sale
98 -0.0%
61.20
US$5,998 		98 -0.0% 61.20 US$5,998
2021-05-05 2021-05-03
PlS Planned sale
3,139 -0.1%
60.08
US$188,591 		3,139 -0.1% 60.08 US$188,591
2021-04-05 2021-04-01
PlS Planned sale
6,184 -0.2%
57.60
US$356,167 		6,184 -0.2% 57.60 US$356,167
2021-04-05 2021-04-01
PlS Planned sale
29,593 -1.1%
56.91
US$1,684,019 		29,593 -1.1% 56.91 US$1,684,019
2021-04-05 2021-04-01
PlS Planned sale
14,223 -0.5%
55.61
US$790,884 		14,223 -0.5% 55.61 US$790,884
2021-03-03 2021-03-01
PlS Planned sale
1,031 -0.0%
71.35
US$73,563 		1,031 -0.0% 71.35 US$73,563
2021-03-03 2021-03-01
PlS Planned sale
3,482 -0.1%
69.59
US$242,309 		3,482 -0.1% 69.59 US$242,309
2021-03-03 2021-03-01
PlS Planned sale
6,011 -0.2%
68.50
US$411,778 		6,011 -0.2% 68.50 US$411,778
2021-03-03 2021-03-01
PlS Planned sale
14,945 -0.6%
67.57
US$1,009,834 		14,945 -0.6% 67.57 US$1,009,834
2021-03-03 2021-03-01
PlS Planned sale
18,316 -0.7%
66.55
US$1,219,003 		18,316 -0.7% 66.55 US$1,219,003
2021-03-03 2021-03-01
PlS Planned sale
37,445 -1.4%
65.63
US$2,457,665 		37,445 -1.4% 65.63 US$2,457,665
2021-03-03 2021-03-01
PlS Planned sale
18,770 -0.7%
64.36
US$1,208,056 		18,770 -0.7% 64.36 US$1,208,056
2020-06-18 2020-06-16
S Sale
400,000 -12.7%
26.10
US$10,440,000 		400,000 -12.7% 26.10 US$10,440,000